Joel W. Hay
Names
| first: |
Joel |
| middle: |
W. |
| last: |
Hay |
Identifer
Contact
Affiliations
-
University of Southern California
/ Leonard D. Schaeffer Center for Health Policy and Economics
Research profile
author of:
- The economic costs of Alzheimer's disease (RePEc:aph:ajpbhl:1987:77:9:1169-1175_7)
by Hay, J.W. & Ernst, R.L. - Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease (RePEc:aph:ajpbhl:1991:81:4:427-433_9)
by Hay, J.W. & Robin, E.D. - The US economic and social costs of Alzheimer's disease revisited (RePEc:aph:ajpbhl:1994:84:8:1261-1264_5)
by Ernst, R.L. & Hay, J.W. - Let Them Eat Cake: A Note on Comparing Alternative Models of the Demand for Medical Care (RePEc:bes:jnlbes:v:2:y:1984:i:3:p:279-82)
by Hay, Joel W & Olsen, Randall J - Ordinary Least Squares and Sample-Selection Models of Health-Care Demand (RePEc:bes:jnlbes:v:5:y:1987:i:4:p:499-506)
by Hay, Joel W & Leu, Robert & Rohrer, Paul - A Procedure for Estimating the Unconditional Cumulative Incidence Curve and its Variability for the Human Immunodeficiency Virus (RePEc:bla:jorssc:v:43:y:1994:i:4:p:599-624)
by Joel W. Hay & Frank A. Wolak - Econometric issues in modeling the costs of AIDS (RePEc:eee:hepoli:v:11:y:1989:i:2:p:125-145)
by Hay, Joel W. - Physician-induced demand : An empirical analysis of the consumer information gap (RePEc:eee:jhecon:v:1:y:1982:i:3:p:231-244)
by Hay, Joel & Leahy, Michael J. - The demand for dental health (RePEc:eee:socmed:v:16:y:1982:i:13:p:1285-1289)
by Hay, Joel W. & Bailit, Howard & Chiriboga, Douglas A. - Where Do I Send Thee? Does Physician-Ownership Affect Referral Patterns to Ambulatory Surgery Centers (RePEc:mpr:mprres:a82b3232352c4cea8e8aeb1e5c0e9d85)
by Jon R. Gabel & Cheryl Fahlman & Ray Kang & Gregory Wozniak & Phil Kletke & Joel W. Hay - Educational Screening and Occupational Earnings (RePEc:nbr:nberwo:0174)
by Edward N. Wolff & Joel Hay - Embedding Health-Promoting Changes Into the Daily Lives of Independent-Living Older Adults (RePEc:oup:geronb:v:56:y:2001:i:1:p:p60-p63)
by Florence Clark & Stanley P. Azen & Mike Carlson & Deborah Mandel & Laurie LaBree & Joel Hay & Ruth Zemke & Jeanne Jackson & Loren Lipson - Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia (RePEc:plo:pone00:0080639)
by Johanna Aponte-González & Luisa Fajardo-Bernal & Jorge Diaz & Javier Eslava-Schmalbach & Oscar Gamboa & Joel W Hay - Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors as First-Line Agents in Rheumatoid Arthritis (RePEc:spr:pharme:v:24:y:2006:i:12:p:1221-1232)
by James Spalding & Joel Hay - Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States (RePEc:spr:pharme:v:31:y:2013:i:9:p:823-839)
by Reginald Villacorta & Joel Hay & Andrew Messali - A Review of the Economic Burden of Glioblastoma and the Cost Effectiveness of Pharmacologic Treatments (RePEc:spr:pharme:v:32:y:2014:i:12:p:1201-1212)
by Andrew Messali & Reginald Villacorta & Joel Hay - A Special Commemorative Issue Honoring William S. Comanor and 50 Years of Pharmaceutical Economics (RePEc:taf:ijecbs:v:22:y:2015:i:2:p:165-168)
by Joel W. Hay - Fee-Screen Reimbursement and Physician Fee Inflation (RePEc:uwp:jhriss:v:20:y:1985:i:2:p:278-291)
by Donald E. Yett, & William Der & Richard L. Ernst & Joel W. Hay - Incremental Expenditure Of Biologic Disease Modifying Antirheumatic Treatment Using Instrumental Variables In Panel Data (RePEc:wly:hlthec:v:22:y:2013:i:7:p:807-823)
by Aniket A. Kawatkar & Joel W. Hay & William Stohl & Michael B. Nichol